Skip to main content

Research Repository

Advanced Search

Monoclonal T-Cell Receptors: New Reagents for Cancer Therapy

Stauss, Hans J.; Cesco-Gaspere, Michela; Thomas, Sharyn; Hart, Daniel P.; Xue, Shao-An; Holler, Angelika; Wright, Graham; Perro, Mario; Little, Ann-Margaret; Pospori, Constantina; King, Judy; Morris, Emma C.

Authors

Hans J. Stauss

Michela Cesco-Gaspere

Sharyn Thomas

Daniel P. Hart

Shao-An Xue

Angelika Holler

Mario Perro

Ann-Margaret Little

Constantina Pospori

Judy King

Emma C. Morris



Abstract

Adoptive transfer of antigen-specific T lymphocytes is an effective form of immunotherapy for persistent virus infections and cancer. A major limitation of adoptive therapy is the inability to isolate antigen-specific T lymphocytes reproducibly. The demonstration that cloned T-cell receptor (TCR) genes can be used to produce T lymphocyte populations of desired specificity offers new opportunities for antigen-specific T-cell therapy. TCR gene-modified lymphocytes display antigen-specific function in vitro, and were shown to protect against virus infection and tumor growth in animal models. A recent trial in humans demonstrated that TCR gene-modified T cells persisted in all and reduced melanoma burden in 2/15 patients. In future trials, it may be possible to use TCR gene transfer to equip helper and cytotoxic T cells with new antigen-specificity, allowing both T-cell subsets to cooperate in achieving improved clinical responses. Sequence modifications of TCR genes are being explored to enhance TCR surface expression, while minimizing the risk of pairing between introduced and endogenous TCR chains. Current T-cell transduction protocols that trigger T-cell differentiation need to be modified to generate “undifferentiated” T cells, which, upon adoptive transfer, display improved in vivo expansion and survival. Both, expression of only the introduced TCR chains and the production of naïve T cells may be possible in the future by TCR gene transfer into stem cells.

Journal Article Type Article
Acceptance Date Apr 26, 2007
Online Publication Date Jul 17, 2017
Publication Date 2007-10
Deposit Date May 4, 2020
Publicly Available Date May 4, 2020
Journal Molecular Therapy
Print ISSN 1525-0016
Publisher Nature Publishing Group
Peer Reviewed Peer Reviewed
Volume 15
Issue 10
Pages 1744-1750
DOI https://doi.org/10.1038/sj.mt.6300216
Keywords Molecular Medicine; Genetics; Molecular Biology; Pharmacology; Drug Discovery
Public URL http://researchrepository.napier.ac.uk/Output/2658366

Files




You might also like



Downloadable Citations